These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 7083785)

  • 41. [Therapeutic action of arginine-thiazolidine-carboxylate (ATCA) as evaluated by liver function tests].
    Alvisĭ V; D'Ambrosi A; Lo Ponte A; Tampieri ML; Tralli M
    Arch Sci Med (Torino); 1980; 137(4):731-8. PubMed ID: 7018458
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Therapeutic effectiveness of thiazolidinecarboxylate of arginine in psychiatric patients with hepatic disorders of toxic origin (alcohol, drugs)].
    Trasatti GA; Ripani G
    Clin Ter; 1979 Nov; 91(4):395-405. PubMed ID: 540484
    [No Abstract]   [Full Text] [Related]  

  • 43. [Acute alcoholic hepatitis and steatosis. Comparative study].
    Vargas V; Esteban R; Pedreira JD; Viladoms J; Allende E; Bacardi R; Guardia J
    Rev Clin Esp; 1979 Oct; 155(1):47-51. PubMed ID: 538288
    [No Abstract]   [Full Text] [Related]  

  • 44. Liver steatosis quantification using magnetic resonance imaging: a prospective comparative study with liver biopsy.
    Mennesson N; Dumortier J; Hervieu V; Milot L; Guillaud O; Scoazec JY; Pilleul F
    J Comput Assist Tomogr; 2009; 33(5):672-7. PubMed ID: 19820490
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis.
    Ito S; Yukawa T; Uetake S; Yamauchi M
    Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S83-7. PubMed ID: 17331172
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Predictive risk factors for progression to cirrhosis in early stage alcoholic liver disease].
    Giraud V; Naveau S; Balian A; Belda E; Capron F; Lemaigre G; Chaput JC
    Gastroenterol Clin Biol; 1998 Dec; 22(12):997-1002. PubMed ID: 10051977
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Arginine thiazolidinecarboxylate in hepatology. Preliminary report].
    Calabrese L; Zoni R
    Minerva Dietol Gastroenterol; 1980; 26(1):51-7. PubMed ID: 7374998
    [No Abstract]   [Full Text] [Related]  

  • 48. Pathological spectrum of alcoholic liver disease.
    Hall PD
    Alcohol Alcohol Suppl; 1994; 2():303-13. PubMed ID: 8974350
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Changes of the biohumoral picture in alcoholic hepatopathy treated with thiazolidinecarboxylate of arginine].
    Zotti S; Bergamo S; Maddalosso T; Salmi A
    Arch Sci Med (Torino); 1979; 136(3):363-8. PubMed ID: 44995
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Correlation between intrasinusoidal neutrophilic infiltration and ceroid-lipofuscinosis in alcoholic liver fibrosis with or without fatty change: clinicopathological comparison with nutritional fatty liver.
    Kishi M; Maeyama S; Koike J; Aida Y; Yoshida H; Uchikoshi T
    Alcohol Clin Exp Res; 1996 Dec; 20(9 Suppl):366A-370A. PubMed ID: 8986240
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hepatitis C virus antibody in alcoholic patients. Association with the presence of portal and/or lobular hepatitis.
    Rosman AS; Paronetto F; Galvin K; Williams RJ; Lieber CS
    Arch Intern Med; 1993 Apr; 153(8):965-9. PubMed ID: 7683191
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Can toxic alcohol liver parenchyma damage be diagnosed using pathobiochemical parameters?].
    Baumgarten R
    Z Arztl Fortbild (Jena); 1993 Apr; 87(5):365-7. PubMed ID: 8100661
    [No Abstract]   [Full Text] [Related]  

  • 53. [Non-cirrhotic alcoholic liver diseases. Pathological anatomy].
    Bedossa P; Martin E
    Rev Prat; 1993 Sep; 43(14):1859-61. PubMed ID: 8310234
    [No Abstract]   [Full Text] [Related]  

  • 54. [Hepatic biopsy in alcoholic hepatopathy].
    Russo M
    Recenti Prog Med; 1985 Mar; 76(3):182-3. PubMed ID: 4012021
    [No Abstract]   [Full Text] [Related]  

  • 55. [Does Hepavis have value in the therapy of fatty liver caused by alcohol poisoning?].
    Odegaard S; Busch D
    Z Gastroenterol; 1989 Feb; 27(2):91-3. PubMed ID: 2658394
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intrahepatic gene expression in human alcoholic hepatitis.
    Seth D; Gorrell MD; Cordoba S; McCaughan GW; Haber PS
    J Hepatol; 2006 Aug; 45(2):306-20. PubMed ID: 16797773
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Alcoholic hepatitis. Clinical, analytical and morphological evaluation].
    Uribarrena R; Borda F; Martínez Peñuela JM; Ayensa C; Burusco MJ; Rivero Puente A
    Rev Clin Esp; 1979 Jul 15-31; 154(1-2):27-32. PubMed ID: 42951
    [No Abstract]   [Full Text] [Related]  

  • 58. [Fatal alcoholic fatty liver].
    Balázs M; Csermely A
    Orv Hetil; 1983 Jun; 124(23):1377-80. PubMed ID: 6877816
    [No Abstract]   [Full Text] [Related]  

  • 59. [Controlled clinical trial in the treatment of chronic hepatopathy of toxico-metabolic etiology].
    Carrara G; Fiocchi G; Sotti A; Dieci MG; Fiorani F; Galvani V
    Clin Ter; 1984 Jun; 109(6):545-55. PubMed ID: 6236945
    [No Abstract]   [Full Text] [Related]  

  • 60. [Histologic evolution of acute alcoholic hepatitis].
    Esteban R; Vargas V; Pedreira JD; Allende E; Guardia J; Bacardí R
    Med Clin (Barc); 1981 Feb; 76(4):172-5. PubMed ID: 7206882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.